Drug intelligence / Profile preview

5HTP-Nat Exts

Development stage: Preclinical
Lead developer: Medestea
Modality: Small Molecules
Administration: Oral

Overview

5HTP-Nat Exts is a dietary supplement formulated as a mouth spray, developed by Medestea Biotech S.p.a. It contains 5-hydroxytryptophan (5-HTP) and unspecified natural extracts. 5-HTP is a naturally occurring amino acid that serves as a metabolic precursor to serotonin, a crucial neurotransmitter in the brain and central nervous system. By increasing serotonin production, 5-HTP influences various physiological processes including mood, sleep, appetite, temperature regulation, sexual behavior, and pain perception. This specific combination product has been investigated for its role in weight management, with early research indicating its potential to enhance weight loss in certain populations.

Brand names: 5HTP-Nat Exts

Beyond the preview

Go deeper on 5HTP-Nat Exts.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 5HTP-Nat Exts.

Explore the full profile